Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts

An amendment to this paper has been published and can be accessed via the original article.

Saved in:
Bibliographic Details
Published in:Journal of translational medicine Vol. 19; no. 1; pp. 1 - 266
Main Authors: Moon, Jeonghyeon, Lee, Seon-yeong, Choi, Jeong Won, Lee, A. Ram, Yoo, Jin Hee, Moon, Su-Jin, Park, Sung-Hwan, Cho, Mi-La
Format: Journal Article
Language:English
Published: London BioMed Central Ltd 21-06-2021
BioMed Central
BMC
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An amendment to this paper has been published and can be accessed via the original article.
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:1479-5876
1479-5876
DOI:10.1186/s12967-021-02916-0